Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-200609
Filing Date
2024-08-14
Accepted
2024-08-14 16:02:11
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d878693d10q.htm   iXBRL 10-Q 1707317
2 EX-3.1 d878693dex31.htm EX-3.1 43672
3 EX-31.1 d878693dex311.htm EX-31.1 10335
4 EX-31.2 d878693dex312.htm EX-31.2 10315
5 EX-32.1 d878693dex321.htm EX-32.1 5137
  Complete submission text file 0001193125-24-200609.txt   6938450

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tecx-20240630.xsd EX-101.SCH 56556
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tecx-20240630_cal.xml EX-101.CAL 50188
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tecx-20240630_def.xml EX-101.DEF 198030
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tecx-20240630_lab.xml EX-101.LAB 445786
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tecx-20240630_pre.xml EX-101.PRE 341353
79 EXTRACTED XBRL INSTANCE DOCUMENT d878693d10q_htm.xml XML 944495
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 241207331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)